Statistics
Publications
3
Citations
80
H-Index
3
Active since
2022
Affiliations
Joel Ho is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and immunotherapy.
Publications per year
2022–2023
3
3
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
Joel Ho, Jane Mattei, Michael T. Tetzlaff et al. · Frontiers in Oncology · 2022 · 52 citations · Full text
Medicine, Immunology, Oncology +17
Lisa Tachiki, Daniel S. Hippe, Karly Williams Silva et al. · Cancer Immunology Immunotherapy · 2023 · 15 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
1–3 of 3